Paliso, Marisa P.
HRN: 21-40-58 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
CO-AMOXICLAV 625MG (TAB)
05/25/2022
06/01/2022
PO
625mg
BID
S/P NSD UTI
Waiting Final Action